Toggle Nav
Close
  • Menu
  • Setting

Anti-Amyloid Beta Antibody (Aducanumab)

Catalog No.
F1525
Anti-Amyloid Beta Antibody (Aducanumab)
Grouped product items
SizePriceStock Qty
100ug
Please inquire
Ship with 3-5 days
1mg
Please inquire
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Aducanumab (BIIB037) is a human monoclonal antibody that selectively targets aggregated amyloid beta (Aβ). Aducanumab exhibits brain penetration and can be used in Alzheimer's disease (AD) research.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

146.2 kDa

Shipping

Dry ice

Cas No.

1384260-65-4

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

Aduhelm, BIIB037, BART

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

P05067

Reactivity

Human, Mouse, Cynomolgus

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

Immobilized N His HSA human Amyloid beta(APP) at 2 ug/mL can bind Anti-Amyloid Beta Antibody (Aducanumab)

Target

Amyloid Beta

Note

Please avoid freeze-thaw cycles.